Design considerations for incorporating sodium iodide symporter reporter gene imaging into prostate cancer gene therapy trials

Human Gene Therapy

Volumn 18, Issue 4, 2007, Pages 312-322

  Siddiqui, Farzan ^a   Barton, Kenneth N ^a   Stricker, Hans J ^b   Steyn, Phillip F ^c   Larue, Susan M ^c   Karvelis, Kastytis C ^a   Sparks, Richard B ^d   Jae, Ho Kim ^a   Brown, Stephen L ^a   Freytag, Svend O ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b HENRY FORD HOSPITAL   (United States)

^c Department of Environmental and Radiological Health Sciences   (United States)

^d CDE Dosimetry Services Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; OCTREOTIDE; SODIUM IODIDE; TECHNETIUM 99M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSIMETRY; GENE EXPRESSION; GENE REPLICATION; GENE THERAPY; HUMAN; MALE; NONHUMAN; PROSTATE CARCINOMA; RADIATION DOSE; REPORTER GENE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TRANSGENE;

ANIMALS; CLINICAL TRIALS, PHASE I; DOGS; GENE THERAPY; GENES, REPORTER; GENETIC VECTORS; HUMANS; MALE; PROSTATIC NEOPLASMS; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; RESEARCH DESIGN; SODIUM PERTECHNETATE TC 99M; SYMPORTERS; TISSUE DISTRIBUTION;

ADENOVIRIDAE; ANIMALIA; CANIS FAMILIARIS;

EID: 34248178694     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2006.131     Document Type: Article

References (32)

1. BARTON, K.N., TYSON, D., STRICKER, H., LEW, Y.S., HEISEY, G., KOUL, S., DE LA ZERDA, A., YIN, F.F., YAN, H., NAGARAJA, T.N., RANDALL, K.A., JIN, G.K., FENSTERMACHER, J.D., JHIANG, S., HO KIM, J., FREYTAG, S.O., and BROWN, S.L. (2003). GENIS: Gene expression of sodium iodide symporter for noninvasive imaging of gene therapy vectors and quantification of gene expression in vivo. Mol. Ther. 8, 508-518.
2. BARTON, K.N., XIA, X., YAN, H., STRICKER, H., HEISEY, G., YIN, F.F., NAGARAJA, T.N., ZHU, G., KOLOZSVARY, A., FENSTERMACHER, J.D., LU, M., KIM, J.H., FREYTAG, S.O., and BROWN, S.L. (2004). A quantitative method for measuring gene expression magnitude and volume delivered by gene therapy vectors. Mol. Ther. 9, 625-631.
3. BARTON, K.N., PAIELLI, D., ZHANG, Y., KOUL, S., BROWN, S.L., LU, M., SEELY, J., KIM, J.H., and FREYTAG, S.O. (2006). Second-generation replication-competent oncolytic adenovirus armed with improved suicide genes and ADP gene demonstrates greater efficacy without increased toxicity. Mol. Ther. 13, 347-356.
4. - symporter in human glioma cells by adenovirus-mediated gene delivery. Gene Ther. 7, 740-749.
5. CHO, J.Y., SHEN, D.H., YANG, W., WILLIAMS, B., BUCKW ALTER, T.L., LA PERLE, K.M., HINKLE, G., POZDERAC, R., KLOOS, R., NAGARAJA, H.N., BARTH, R.F., and JHIANG, S.M. (2002). In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomas. Gene Ther. 9, 1139-1145.
6. DENG, W.P., YANG, W.K., LAI, W.F., LIU, R.S., HWANG, J.J., YANG, D.M., FU, Y.K., and WANG, H.E. (2004). Non-invasive in vivo imaging with radiolabeled FIAU for monitoring cancer gene therapy using herpes simplex virus type 1 thymidine kinase and ganciclovir. Eur. J. Nucl. Med. Mol. Imaging 31, 99-109.
7. FREYTAG, S.O., ROGULSKI, K.R., PAIELLI, D.L., GILBERT, J.D., and KIM, J.H. (1998). A novel three-pronged approach to kill cancer cells selectively: Concomitant viral, double suicide gene, and radiotherapy. Hum. Gene Ther. 9, 1323-1333.
8. FREYTAG, S.O., KHIL, M., STRICKER, H., PEABODY, J., MENON, M., DEPERALTA-VENTURINA, M., NAFZIGER, D., PEGG, J., PAIELLI, D., BROWN, S., BARTON, K., LU, M., AGUILAR-CORDOVA, E., and KIM, J.H. (2002a). Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer. Cancer Res. 62, 4968-4976.
9. FREYTAG, S.O., PAIELLI, D., WING, M., ROGULSKI, K., BROWN, S., KOLOZSVARY, A., SEELY, J., BARTON, K., DRAGOVIC, A., and KIM, J.H. (2002b). Efficacy and toxicity of replication-competent adenovirus-mediated double suicide gene therapy in combination with radiation therapy in an orthotopic mouse prostate cancer model. Int. J. Radiat. Oncol. Biol. Phys. 54, 873-885.
10. FREYTAG, S.O., STRICKER, H., PEGG, J., PAIELLI, D., PRADHAN, D.G., PEABODY, J., DEPERALTA-VENTURINA, M., XIA, X., BROWN, S., LU, M., and KIM, J.H. (2003). Phase I study of replication-competent adenovirus-mediated double-suicide gene therapy in combination with conventional-dose three-dimensional conformal radiation therapy for the treatment of newly diagnosed, intermediate- to high-risk prostate cancer. Cancer Res. 63, 7497-7506.
11. FREYTAG, S.O., KIM, J.H., BROWN, S.L., BARTON, K., LU, M., and CHUNG, M. (2004). Gene therapy strategies to improve the effectiveness of cancer radiotherapy. Expert Opin. Biol. Ther. 4, 1757-1770.
12. GAMBHIR, S.S., BARRIO, J.R., PHELPS, M.E., IYER, M., NAMAVARI, M., SATYAMURTHY, N., WU, L., GREEN, L.A., BAUER, E., MACLAREN, D.C., NGUYEN, K., BERK, A.J., CHERRY, S.R., and HERSCHMAN, H.R. (1999). Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc. Natl. Acad. Sci. U.S.A. 96, 2333-2338.
13. GROOT-WASSINK, T., ABOAGYE, E.O., GLASER, M., LEMOINE, N.R., and VASSAUX, G. (2002). Adenovirus biodistribution and noninvasive imaging of gene expression in vivo by positron emission tomography using human sodium/iodide symporter as reporter gene. Hum. Gene Ther. 13, 1723-1735.
14. HERSCHMAN, H.R., MACLAREN, D.C., IYER, M., NAMAVARI, M., BOBINSKI, K., GREEN, L.A., WU, L., BERK, A.J., TOYOKUNI, T., BARRIO, J.R., CHERRY, S.R., PHELPS, M.E., SANDGREN, E.P., and GAMBHIR, S.S. (2000). Seeing is believing: Non-invasive, quantitative and repetitive imaging of reporter gene expression in living animals, using positron emission tomography. J. Neurosci. Res. 59, 699-705.
15. JACOBS, A., and HEISS, W.D. (2002). Towards non-invasive imaging of HSV-1 vector-mediated gene expression by positron emission tomography. Vet. Microbiol. 86, 27-36.
16. JACOBS, A., VOGES, J., RESZKA, R., LERCHER, M., GOSSMANN, A., KRACHT, L., KAESTLE, C., WAGNER, R., WIENHARD, K., and HEISS, W.D. (2001). Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet 358, 727-729.
17. KIM, J.H., KIM, S.H., BROWN, S.L., and FREYTAG, S.O. (1994). Selective enhancement by an antiviral agent of the radiation-induced cell killing of human glioma cells transduced with HSV-tk gene. Cancer Res. 54, 6053-6056.
18. KIM, J.H., KOLOZSVARY, A., ROGULSKI, K., KHIL, M.S., BROWN, S.L., and FREYTAG, S.O. (1998). Selective radiosensitization of 9L glioma in the brain transduced with double suicide fusion gene. Cancer J. Sci. Am. 4, 364-369.
19. LA PERLE, K.M., SHEN, D., BUCKWALTER, T.L., WILLIAMS, B., HAYNAM, A., HINKLE, G., POZDERAC, R., CAPEN, C.C., and JHIANG, S.M. (2002). In vivo expression and function of the sodium iodide symporter following gene transfer in the MATLyLu rat model of metastatic prostate cancer. Prostate 50, 170-178.
20. LOEVINGER, R., and BERMAN, M. (1968). A formalism for calculation of absorbed dose from radionuclides. Phys. Med. Biol. 13, 205-217.
21. MARSEE, D.K., SHEN, D.H., MACDONALD, L.R., VADYSIRISACK, D.D., LIN, X., HINKLE, G., KLOOS, R.T., and JHIANG, S.M. (2004). Imaging of metastatic pulmonary tumors following NIS gene transfer using single photon emission computed tomography. Cancer Gene Ther. 11, 121-127.
22. 99mTc as sodium pertechnetate. J. Nucl. Med. 17, 74-77.
23. MIYAGAWA, M., ANTON, M., WAGNER, B., HAUBNER, R., SOUVATZOGLOU, M., GANSBACHER, B., SCHWAIGER, M., and BENGEL, F.M. (2005). Non-invasive imaging of cardiac transgene expression with PET: Comparison of the human sodium/iodide symporter gene and HSV1-tk as the reporter gene. Eur. J. Nucl. Med. Mol. Imaging 32, 1108-1114.
24. NIU, G., KRAGER, K.J., GRAHAM, M.M., HICHWA, R.D., and DOMANN, F.E. (2005). Noninvasive radiological imaging of pulmonary gene transfer and expression using the human sodium iodide symporter. Eur. J. Nucl. Med. Mol. Imaging 32, 534-540.
25. PENUELAS, I., MAZZOLINI, G., BOAN, J.F., SANGRO, B., MARTI-CLIMENT, J., RUIZ, M., RUIZ, J., SATYAMURTHY, N., QIAN, C., BARRIO, J.R., PHELPS, M.E., RICHTER, J.A., GAMBHIR, S.S., and PRIETO, J. (2005). Positron emission tomography imaging of adenoviral-mediated transgene expression in liver cancer patients. Gastroenterology 128, 1787-1795.
26. ROGULSKI, K.R., KIM, J.H., KIM, S.H., and FREYTAG, S.O. (1997a). Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity. Hum. Gene Ther. 8, 73-85.
27. ROGULSKI, K.R., ZHANG, K., KOLOZSVARY, A., KIM, J.H., and FREYTAG, S.O. (1997b). Pronounced antitumor effects and tumor radiosensitization of double suicide gene therapy. Clin. Cancer Res. 3, 2081-2088.
28. SIEGEL, J.A., THOMAS, S.R., STUBBS, J.B., STABIN, M.G., HAYS, M.T., KORAL, K.F., ROBERTSON, J.S., HOWELL, R.W., WESSELS, B.W., FISHER, D.R., WEBER, D.A., and BRILL, A.B. (1999). MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. J. Nucl. Med. 40, 37S-61S.
29. STABIN, M.G. (1994). A model of the prostate gland for use in internal dosimetry. J. Nucl. Med. 35, 516-520.
30. STABIN, M.G. (1996). MIRDOSE: Personal computer software for internal dose assessment in nuclear medicine. J. Nucl. Med. 37, 538-546.
31. 18F]FHBG: A reporter probe for imaging herpes simplex virus type-1 thymidine kinase reporter gene expression. J. Nucl. Med. 42, 1225-1234.
32. YAGHOUBI, S.S., BARRIO, J.R., NAMAVARI, M., SATYAMURTHY, N., PHELPS, M.E., HERSCHMAN, H.R., and GAMBHIR, S.S. (2005). Imaging progress of herpes simplex virus type 1 thymidine kinase suicide gene therapy in living subjects with positron emission tomography. Cancer Gene Ther. 12, 329-339.